CS logo
small CS logo
Chungbuk National University

Cheongju, Chungcheongbuk-Do, Korea, Republic of
National university in Cheongju
Chungcheongbuk-do, Cheongju-si, 서원구 충대로 1

About Chungbuk National University


Chungbuk National University is one of ten Flagship Korean National Universities. It takes its name, Chungbuk, from the common abbreviated form of the province's Korean name Chungcheongbuk-do.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Chungbuk National University


During the past decade, Chungbuk National University conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias
2003-07-01
2012-12-01
Unknown status
6,000
Oral Cladribine in Early Multiple Sclerosis (MS)
2008-12-31
2012-04-30
Completed
617
Lithium in Multiple System Atrophy
2009-10-01
2011-08-01
Terminated
10
Safety and Tolerability of Lithium in Spinocerebellar Ataxia 2 (SCA2)
2009-10-01
2012-11-01
Completed
20
Efficacy Study of Epoetin Alfa in Friedreich Ataxia
2013-01-01
2015-06-01
Completed
56
A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)
2016-09-09
2020-12-15
Completed
681
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
2017-03-24
2024-08-15
Active, not recruiting
1,239
A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis
2018-05-28
2026-12-04
Active, not recruiting
927

Rows per page:

1–12 of 12

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Chungbuk National University


According to Clinical.Site data, the most researched conditions in "Chungbuk National University" are "Obesity" (2 trials) and "Diabetes" (1 trials). Many other conditions were trialed in "Chungbuk National University" in a lesser frequency.

Clinical Trials Intervention Types at Chungbuk National University


Most popular intervention types in "Chungbuk National University" are "Device" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Integrated Diabetes Management Protocol" (1 trials), "Standard Diabetes Management Protocol" (1 trials), "real tDCS" (1 trials), "sham tDCS" (1 trials) and "tDCS" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Chungbuk National University


The vast majority of trials in "Chungbuk National University" are 3 trials for "All" genders.

Clinical Trials Status at Chungbuk National University


Currently, there are NaN active trials in "Chungbuk National University". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Chungbuk National University, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Chungbuk National University, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status